Citius Pharmaceuticals Inc vs SPDR Gold Trust — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while SPDR Gold Trust trades at $404.76. The key difference: SPDR Gold Trust is trading nearer its 52-week high, Citius Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| CTXR | GLD | |
|---|---|---|
Market Cap | $20.01M | — |
Sector | Health | — |
52-Week High | $1.82 | $495.90 |
52-Week Low | $0.48 | $305.27 |
Enterprise Value | $16.23M | — |
Trailing returns across standard periods
Latest headlines on both assets
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →GLD is the largest physically backed gold ETF in the world. It offers investors a cost-efficient and secure way to track the price of gold bullion without the need for physical storage.
Read more on GLD →